9-136429577-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_019892.6(INPP5E):c.*98G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.254 in 1,510,922 control chromosomes in the GnomAD database, including 52,271 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.20 ( 3770 hom., cov: 32)
Exomes 𝑓: 0.26 ( 48501 hom. )
Consequence
INPP5E
NM_019892.6 3_prime_UTR
NM_019892.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.846
Genes affected
INPP5E (HGNC:21474): (inositol polyphosphate-5-phosphatase E) The protein encoded by this gene is an inositol 1,4,5-trisphosphate (InsP3) 5-phosphatase. InsP3 5-phosphatases hydrolyze Ins(1,4,5)P3, which mobilizes intracellular calcium and acts as a second messenger mediating cell responses to various stimulation. Studies of the mouse counterpart suggest that this protein may hydrolyze phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,5-bisphosphate on the cytoplasmic Golgi membrane and thereby regulate Golgi-vesicular trafficking. Mutations in this gene cause Joubert syndrome; a clinically and genetically heterogenous group of disorders characterized by midbrain-hindbrain malformation and various associated ciliopathies that include retinal dystrophy, nephronophthisis, liver fibrosis and polydactyly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 9-136429577-C-T is Benign according to our data. Variant chr9-136429577-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 365877.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.276 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INPP5E | NM_019892.6 | c.*98G>A | 3_prime_UTR_variant | 10/10 | ENST00000371712.4 | NP_063945.2 | ||
INPP5E | NM_001318502.2 | c.*98G>A | 3_prime_UTR_variant | 10/10 | NP_001305431.1 | |||
INPP5E | XM_017014926.2 | c.*177G>A | 3_prime_UTR_variant | 10/10 | XP_016870415.1 | |||
INPP5E | XM_047423603.1 | c.*177G>A | 3_prime_UTR_variant | 10/10 | XP_047279559.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INPP5E | ENST00000371712 | c.*98G>A | 3_prime_UTR_variant | 10/10 | 1 | NM_019892.6 | ENSP00000360777.3 | |||
INPP5E | ENST00000676019 | c.*98G>A | 3_prime_UTR_variant | 10/10 | ENSP00000501984.1 |
Frequencies
GnomAD3 genomes AF: 0.205 AC: 31146AN: 152074Hom.: 3770 Cov.: 32
GnomAD3 genomes
AF:
AC:
31146
AN:
152074
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.259 AC: 352103AN: 1358730Hom.: 48501 Cov.: 21 AF XY: 0.256 AC XY: 174396AN XY: 681010
GnomAD4 exome
AF:
AC:
352103
AN:
1358730
Hom.:
Cov.:
21
AF XY:
AC XY:
174396
AN XY:
681010
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.205 AC: 31161AN: 152192Hom.: 3770 Cov.: 32 AF XY: 0.202 AC XY: 15019AN XY: 74412
GnomAD4 genome
AF:
AC:
31161
AN:
152192
Hom.:
Cov.:
32
AF XY:
AC XY:
15019
AN XY:
74412
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
446
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 26, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Joubert syndrome 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at